Tvardi Therapeutics, Inc. (TVRD) — Dilution Risk Analysis

Current Snapshot

Tvardi Therapeutics, Inc. (TVRD) has a DilutionWatch score of 86/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
13,338,943 Source
Public Float
6,461,494 Source
Float as % of Outstanding
48.4%

Dilution Risk Score

Score: 86/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 424B3 1, 4 4, XBRL 1.

FormFiledAccession
424B3 2026-03-06 0001104659-26-024686
4 2026-02-02 0002064884-26-000002
4 2026-02-02 0002064881-26-000002
4 2026-02-02 0002064982-26-000002
4 2026-02-02 0002064889-26-000002
xbrl 2025-12-31 xbrl-6231-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 3 months Source
Three-year share count growth 144.84% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 86/10) Source
Cash Runway
3 months Source
Share Count Growth (3-Year)
144.84% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.